Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors

Clinical trial NCT06572956 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06572956
Sponsor: The Second Hospital of Shandong University
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Safety and Efficacy of Cellular Drugs, Objective Response Rate of Subjects, Etc

Start date: 2024-03-21
Primary completion: 2025-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.